Effect of a newly developed pastille on the salivary flow rate in subjects with dry mouth symptoms: a randomized, controlled, monocentric clinical study
Autor: | D. Wilhelm, K. P. Wilhelm, C. Neumeister, Stephan Bielfeldt, U. Schwantes |
---|---|
Rok vydání: | 2021 |
Předmět: |
Dry mouth
Saliva Side effect Visual analogue scale Saliva surface tension Saliva secretion Dentistry Pastille Xerostomia Chewing Gum stomatognathic system Throat Salivary flow rate medicine Humans General Dentistry Aged Medical device business.industry Raman spectroscopy of saliva lcsh:RK1-715 stomatognathic diseases medicine.anatomical_structure lcsh:Dentistry Oral and maxillofacial surgery medicine.symptom Salivation Secretory Rate business Research Article |
Zdroj: | BMC Oral Health, Vol 21, Iss 1, Pp 1-10 (2021) BMC Oral Health |
ISSN: | 1472-6831 |
Popis: | Background Xerostomia is associated with several diseases and is a side effect of certain drugs, resulting from reduced saliva secretion. Often, aged and sometimes younger people suffer from (idiopathic) xerostomia. Chewing gum and sucking pastilles may relieve symptoms of xerostomia by increasing the salivary flow rate due to the mechanical effect of sucking and gustatory stimulation. Swallowing problems and the urge to cough or experiencing a tickling sensation in the throat might be alleviated through a reduction in dry mouth symptoms. We investigated whether a pastille containing four polysaccharides increased the salivary flow rate and relieved the symptoms of dry mouth. Methods Participating subjects with xerostomia were randomized into two equally balanced treatment groups. Subjects received the pastille on Day 1 and a control product (Parafilm®) on Day 3, or vice versa. Unstimulated saliva was collected every 2.5 min for 0–10 min. Stimulated saliva was collected after subjects sucked the pastille or the control product. The salivary flow rate was determined gravimetrically, and, in parallel, the feeling of dry mouth was assessed using a visual analog scale. Saliva surface tension was measured in pooled saliva samples (0–5 min of sampling). Additionally, in stimulated saliva from six subjects who sucked the pastille, the presence of the main ingredient—gum arabic—was examined by Raman spectroscopy. Results Chewing the pastille significantly increased the mean salivary flow rate by 8.03 g/10 min compared to the mean changes after chewing the control product (+ 3.71 g/10 min; p Conclusions The pastille was well tolerated and effective in increasing the salivary flow rate and reducing mouth dryness after sucking. These results were in line with the detection of the main ingredient, gum arabic, in saliva for up to 10 min after sucking the pastille. Trial registration German Register Clinical Trials (Deutsches Register Klinische Studien, DRKS) DRKS-ID: DRKS00017393, Registered 29 May 2019, https://www.drks.de/drks_web/navigate.do?navigationId=trial. HTML&TRIAL_ID = DRKS00017393. |
Databáze: | OpenAIRE |
Externí odkaz: |